Cleared Traditional

K982166 - CYTO-STAT TRICHROME CD45-FITC/CD56-RD1/CD3-PC5 MONOCLONAL ANTIBODY REAGENT WITH CYTO-STAT TRICHROME CD45-FITC/MSIGG1-RD1
(FDA 510(k) Clearance)

Nov 1998
Decision
139d
Days
Class 2
Risk

K982166 is an FDA 510(k) clearance for the CYTO-STAT TRICHROME CD45-FITC/CD56-RD1/CD3-PC5 MONOCLONAL ANTIBODY REAGENT WITH CYTO-STAT TRICHROME CD45-FITC/MSIGG1-RD1. This device is classified as a Counter, Differential Cell (Class II - Special Controls, product code GKZ).

Submitted by Coulter Corp. (Miami, US). The FDA issued a Cleared decision on November 5, 1998, 139 days after receiving the submission on June 19, 1998.

This device falls under the Hematology FDA review panel. Regulated under 21 CFR 864.5220.

Submission Details

510(k) Number K982166 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 19, 1998
Decision Date November 05, 1998
Days to Decision 139 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF

Device Classification

Product Code GKZ — Counter, Differential Cell
Device Class Class II - Special Controls
CFR Regulation 21 CFR 864.5220